{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:39:01Z","timestamp":1781123941907,"version":"3.54.1"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>There has been intense research focus on the biological mechanisms underlying the transition from health to disease for rheumatoid arthritis (RA) over recent years, and it is now well established that a state of autoimmunity precedes the development of symptoms for a large proportion of patients. This has led to an increased interest in the identification of at-risk groups and the potential for preventive intervention. The ability of several immunomodulatory agents to delay or prevent RA is under investigation and novel cellular therapies are in development. Preventive approaches are also being assessed in other chronic autoimmune diseases. For example, an anti-CD3 antibody has recently been shown to delay progression to type 1 diabetes in non-diabetic relatives of patients identified as being at high risk. The identification and treatment of individuals as being at risk of a disease where there is a degree of uncertainty around the potential for benefit is socially and ethically challenging. Recently reported difficulties in recruitment to RA prevention trials have underlined the importance of understanding the perspectives of at-risk individuals to identify barriers and facilitators that need to be addressed in order for preventive strategies to be acceptable. Understanding of their preferences for benefits and risks of preventive interventions can inform efficient intervention prioritization, prevention trial design and the development of informational resources for those at risk. In this review we summarize current knowledge of preferences for RA prevention and make recommendations for further research needed to ensure efficient development of preventive therapies and clinical implementation.<\/jats:p>","DOI":"10.3389\/fimmu.2022.883287","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T05:41:11Z","timestamp":1651210871000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Perspectives of at-Risk Individuals on Preventive Intervention for Rheumatoid Arthritis: A Mini Review"],"prefix":"10.3389","volume":"13","author":[{"given":"Marie","family":"Falahee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR Recommendations for the Management of Rheumatoid Arthritis With Synthetic and Biological Disease-Modifying Antirheumatic Drugs: 2019 Update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217344","article-title":"EULAR Definition of Difficult-to-Treat Rheumatoid Arthritis","volume":"80","author":"Nagy","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B3","unstructured":"The Burden of Rheumatoid Arthritis Across Europe: A Socioeconomic Survey (BRASS) - Summary Report"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216243","article-title":"Economic Burden of Rheumatoid Arthritis: A Systematic Review of Literature in Biologic Era","volume":"79","author":"Hsieh","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/art.27692","article-title":"Long-Term Impact of Delay in Assessment of Patients With Early Arthritis","volume":"62","author":"van der Linden","year":"2010","journal-title":"Arthritis Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/rheumatology\/kev261","article-title":"Predicting and Preventing the Development of Rheumatoid Arthritis","volume":"55","author":"Raza","year":"2016","journal-title":"Rheumatology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-017-0620-6","article-title":"Pre-Symptomatic Autoimmunity in Rheumatoid Arthritis: When Does the Disease Start","volume":"39","author":"Tracy","year":"2017","journal-title":"Semin Immunopathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.04.017","article-title":"Predicting Rheumatoid Arthritis in At-Risk Individuals","volume":"41","author":"van Boheemen","year":"2019","journal-title":"Clin Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu159","article-title":"Symptom Complexes in Patients With Seropositive Arthralgia and in Patients Newly Diagnosed With Rheumatoid Arthritis: A Qualitative Exploration of Symptom Development","volume":"53","author":"Stack","year":"2014","journal-title":"Rheumatology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200990","article-title":"EULAR Recommendations for Terminology and Research in Individuals at Risk of Rheumatoid Arthritis: Report From the Study Group for Risk Factors for Rheumatoid Arthritis","volume":"71","author":"Gerlag","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/art.38097","article-title":"Familial Risks and Heritability of Rheumatoid Arthritis: Role of Rheumatoid Factor\/Anti\u2013Citrullinated Protein Antibody Status, Number and Type of Affected Relatives, Sex, and Age","volume":"65","author":"Frisell","year":"2013","journal-title":"Arthritis Rheumatism"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.120899","article-title":"Smoking is a Major Preventable Risk Factor for Rheumatoid Arthritis: Estimations of Risks After Various Exposures to Cigarette Smoke","volume":"70","author":"Kallberg","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209846","article-title":"EULAR Definition of Arthralgia Suspicious for Progression to Rheumatoid Arthritis","volume":"76","author":"van Steenbergen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001768","article-title":"A Core Set of Risk Factors in Individuals at Risk of Rheumatoid Arthritis: A Systematic Literature Review Informing the EULAR Points to Consider for Conducting Clinical Trials and Observational Studies in Individuals at Risk of Rheumatoid Arthritis","volume":"7","author":"Mankia","year":"2021","journal-title":"RMD Open"},{"key":"B15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/annrheumdis-2021-221160","article-title":"Perceptions and Experiences of Individuals at-Risk of Rheumatoid Arthritis (RA) Knowing About Their Risk of Developing RA and Being Offered Preventive Treatment: Systematic Review and Thematic Synthesis of Qualitative Studies","volume":"81","author":"Siddle","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220884","article-title":"EULAR Points to Consider for Conducting Clinical Trials and Observational Studies in Individuals at Risk of Rheumatoid Arthritis","volume":"80","author":"Mankia","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.105767","article-title":"Effect of Dexamethasone on Autoantibody Levels and Arthritis Development in Patients With Arthralgia: A Randomised Trial","volume":"69","author":"Bos","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.119149","article-title":"Beneficial Effects of a 3-Week Course of Intramuscular Glucocorticoid Injections in Patients With Very Early Inflammatory Polyarthritis: Results of the STIVEA Trial","volume":"69","author":"Verstappen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212763","article-title":"Effects of B-Cell Directed Therapy on the Preclinical Stage of Rheumatoid Arthritis: The PRAIRI Study","volume":"78","author":"Gerlag","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13063-019-3403-7","article-title":"Arthritis Prevention in the Pre-Clinical Phase of RA With Abatacept (the APIPPRA Study): A Multi-Centre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Clinical Trial Protocol","volume":"20","author":"Al-Laith","year":"2019","journal-title":"Trials"},{"key":"B21","unstructured":"Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis (StopRA)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902226","article-title":"An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"New Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-066452","article-title":"Vitamin D and Marine Omega 3 Fatty Acid Supplementation and Incident Autoimmune Disease: VITAL Randomized Controlled Trial","volume":"376","author":"Hahn","year":"2022","journal-title":"BMJ"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev266","article-title":"Lower Omega-3 Fatty Acids are Associated With the Presence of Anti-Cyclic Citrullinated Peptide Autoantibodies in a Population at Risk for Future Rheumatoid Arthritis: A Nested Case-Control Study","volume":"55","author":"Gan","year":"2016","journal-title":"Rheumatol (Oxford England)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209154","article-title":"Omega-3 Fatty Acids are Associated With a Lower Prevalence of Autoantibodies in Shared Epitope-Positive Subjects at Risk for Rheumatoid Arthritis","volume":"76","author":"Gan","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12891-018-2381-3","article-title":"Association of Fish Intake and Smoking With Risk of Rheumatoid Arthritis and Age of Onset: A Prospective Cohort Study","volume":"20","author":"Sparks","year":"2019","journal-title":"BMC Musculoskel Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1086\/516736","article-title":"Gene-Gene and Gene-Environment Interactions Involving HLA-DRB1, PTPN22, and Smoking in Two Subsets of Rheumatoid Arthritis","volume":"80","author":"Kallberg","year":"2007","journal-title":"Am J Hum Genet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.09.053","article-title":"Smoking Intensity, Duration, and Cessation, and the Risk of Rheumatoid Arthritis in Women","volume":"119","author":"Costenbader","year":"2006","journal-title":"Am J Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s10067-016-3519-z","article-title":"Are Obesity, ACPAs and Periodontitis Conditions That Influence the Risk of Developing Rheumatoid Arthritis in First-Degree Relatives","volume":"36","author":"Unriza-Puin","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048296","article-title":"Burden of Chronic Diseases Associated With Periodontal Diseases: A Retrospective Cohort Study Using UK Primary Care Data","volume":"11","author":"Zemedikun","year":"2021","journal-title":"BMJ Open"},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.4324\/9780429341038-6","article-title":"Genomic and Biological Risk Profiling: From Medicalization to Empowerment","volume-title":"Ethical, Social and Psychological Impacts of Genomic Risk Communication","author":"Hansson","year":"2020"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1080\/13669877.2016.1153503","article-title":"Healthcare Professionals\u2019 Perceptions of Risk in the Context of Genetic Testing for the Prediction of Chronic Disease: A Qualitative Metasynthesis","volume":"21","author":"Falahee","year":"2018","journal-title":"J Risk Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001591","article-title":"Atorvastatin is Unlikely to Prevent Rheumatoid Arthritis in High Risk Individuals: Results From the Prematurely Stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) Trial","volume":"7","author":"van Boheemen","year":"2021","journal-title":"RMD Open"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001592","article-title":"How to Enhance Recruitment of Individuals at Risk of Rheumatoid Arthritis Into Trials Aimed at Prevention: Understanding the Barriers and Facilitators","volume":"7","author":"van Boheemen","year":"2021","journal-title":"RMD Open"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-017-0222-3","article-title":"Giving Patients\u2019 Preferences a Voice in Medical Treatment Life Cycle: The PREFER Public\u2013Private Project","volume":"10","author":"de Bekker-Grob","year":"2017","journal-title":"Patient: Patient Centred Outcomes Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-014-4044-2","article-title":"Incorporating Patient-Preference Evidence Into Regulatory Decision Making","volume":"29","author":"Ho","year":"2015","journal-title":"Surg Endosc"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-019-00408-4","article-title":"Use of Patient Preference Studies in HTA Decision Making: A NICE Perspective","volume":"13","author":"Bouvy","year":"2020","journal-title":"patient"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.02.019","article-title":"A Framework for Incorporating Patient Preferences Regarding Benefits and Risks Into Regulatory Assessment of Medical Technologies","volume":"19","author":"Ho","year":"2016","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.11.009","article-title":"Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group","volume":"23","author":"Marsh","year":"2020","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv590","article-title":"Factors Affecting Uptake and Adherence to Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis","volume":"27","author":"Smith","year":"2016","journal-title":"Ann Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2012.05.007","article-title":"Proportion and Risk Indicators of Nonadherence to Statin Therapy: A Meta-Analysis","volume":"28","author":"Lemstra","year":"2012","journal-title":"Can J Cardiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2013.05.005","article-title":"Primary Prevention of Rheumatoid Arthritis: A Qualitative Study in a High-Risk Population","volume":"80","author":"Novotny","year":"2013","journal-title":"Joint Bone Spine"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3038-3","article-title":"Views on Clinically Suspect Arthralgia: A Focus Group Study","volume":"35","author":"Newsum","year":"2016","journal-title":"Clin Rheumatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010555","article-title":"Perceptions of Risk and Predictive Testing Held by the First-Degree Relatives of Patients With Rheumatoid Arthritis in England, Austria and Germany: A Qualitative Study","volume":"6","author":"Stack","year":"2016","journal-title":"BMJ Open"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23179","article-title":"Patients' Perceptions of Their Relatives' Risk of Developing Rheumatoid Arthritis and of the Potential for Risk Communication, Prediction, and Modulation","volume":"69","author":"Falahee","year":"2017","journal-title":"Arthrit Care Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s41927-018-0038-3","article-title":"Perceptions of First-Degree Relatives of Patients With Rheumatoid Arthritis About Lifestyle Modifications and Pharmacological Interventions to Reduce the Risk of Rheumatoid Arthritis Development: A Qualitative Interview Study","volume":"2","author":"Simons","year":"2018","journal-title":"BMC Rheumatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41927-018-0026-7","article-title":"Perspectives of patients, first-degree relatives and rheumatologists on preventive treatments for rheumatoid arthritis: a qualitative analysis","volume":"2","author":"Munro","year":"2018","journal-title":"BMC Rheumatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23841","article-title":"I Would Never Take Preventive Medication! Perspectives and Information Needs of People Who Underwent Predictive Tests for Rheumatoid Arthritis","volume":"72","author":"Mosor","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41927-021-00244-w","article-title":"Public Perceptions of Predictive Testing for Rheumatoid Arthritis Compared to Breast Cancer and Early-Onset Alzheimer\u2019s Disease: A Qualitative Study","volume":"6","author":"Singhal","year":"2022","journal-title":"BMC Rheumatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2018.12.011","article-title":"Effect of Communicating Personalized Rheumatoid Arthritis Risk on Concern for Developing RA: A Randomized Controlled Trial","volume":"102","author":"Marshall","year":"2019","journal-title":"Patient Educ Couns"},{"key":"B51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11926-016-0598-4","article-title":"Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences","volume":"18","author":"Finckh","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0216075","DOI":"10.1371\/journal.pone.0216075","article-title":"Preventing Rheumatoid Arthritis: Preferences for and Predicted Uptake of Preventive Treatments Among High Risk Individuals","volume":"14","author":"Harrison","year":"2019","journal-title":"PloS One"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05072-w","article-title":"Preferences for Treatments to Prevent Rheumatoid Arthritis in Canada and the Influence of Shared Decision-Making","volume":"39","author":"Harrison","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13075-020-02314-9","article-title":"Patients\u2019 and Rheumatologists\u2019 Perceptions on Preventive Intervention in Rheumatoid Arthritis and Axial Spondyloarthritis","volume":"22","author":"van Boheemen","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab890","article-title":"Predictors of Interest in Predictive Testing for Rheumatoid Arthritis Amongst First Degree Relatives of Rheumatoid Arthritis Patients","author":"Wells","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181165","article-title":"Patient Preferences for Disease-Modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis: A Systematic Review","volume":"47","author":"Durand","year":"2020","journal-title":"J Rheumatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13075-021-02707-4","article-title":"Systematic Review of Quantitative Preference Studies of Treatments for Rheumatoid Arthritis Among Patients and at-Risk Populations","volume":"24","author":"Simons","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045851","article-title":"Treatment Preferences for Preventive Interventions for Rheumatoid Arthritis: Protocol of a Mixed Methods Case Study for the Innovative Medicines Initiative PREFER Project","volume":"11","author":"Falahee","year":"2021","journal-title":"BMJ Open"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-eular.2168","article-title":"OP0160-HPR Preferences For Treatments To Prevent Rheumatoid Arthritis: Discrete Choice Survey Of General Populations In United Kingdom, Germany, And Romania","volume":"80","author":"Simons","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.04.015","article-title":"Preferences of Patients and At-Risk Individuals for Preventive Approaches to Rheumatoid Arthritis","volume":"41","author":"Falahee","year":"2019","journal-title":"Clin Ther"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140913","article-title":"A Qualitative Investigation of the Barriers to Help-Seeking Among Members of the Public Presented With Symptoms of New-Onset Rheumatoid Arthritis","volume":"42","author":"Simons","year":"2015","journal-title":"J Rheumatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/msc.1135","article-title":"Qualitative Exploration of Illness Perceptions of Rheumatoid Arthritis in the General Public","volume":"15","author":"Simons","year":"2017","journal-title":"Musculoskeletal Care"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22979","article-title":"Symptom Recognition and Perceived Urgency of Help-Seeking for Rheumatoid Arthritis and Other Diseases in the General Public: A Mixed Method Approach","volume":"69","author":"Simons","year":"2017","journal-title":"Arthrit Care Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23411","article-title":"Disclosure of Personalized Rheumatoid Arthritis Risk Using Genetics, Biomarkers, and Lifestyle Factors to Motivate Health Behavior Improvements: A Randomized Controlled Trial","volume":"70","author":"Sparks","year":"2018","journal-title":"Arthrit Care Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S261615","article-title":"Taking Into Account Patient Preferences: A Consensus Study on the Assessment of Psychological Dimensions Within Patient Preference Studies","volume":"15","author":"Russo","year":"2021","journal-title":"Patient Prefer Adherence"},{"key":"B66","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jval.2018.12.007","article-title":"Understanding Patients' Preferences: A Systematic Review of Psychological Instruments Used in Patients' Preference and Decision Studies","volume":"22","author":"Russo","year":"2019","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2021.03.013","article-title":"Does Being Exposed to an Educational Tool Influence Patient Preferences? The Influence of an Educational Tool on Patient Preferences Assessed by a Discrete Choice Experiment","volume":"104","author":"Bywall","year":"2021","journal-title":"Patient Educ Couns"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.883287\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T05:41:18Z","timestamp":1651210878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.883287\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":67,"alternative-id":["10.3389\/fimmu.2022.883287"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.883287","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"article-number":"883287"}}